ACCOLATE

This brand name is authorized in Mexico, United States, South Africa

Active ingredients

The drug ACCOLATE contains one active pharmaceutical ingredient (API):

1 Zafirlukast UNII XZ629S5L50 - ZAFIRLUKAST

Zafirlukast is a selective and competitive receptor antagonist of leukotriene D4 and E4 (LTD4 and LTE4), components of slowreacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma. Read about Zafirlukast

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACCOLATE Coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03DC01	Zafirlukast	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 360M97
Country: US	FDA, National Drug Code	Identifier(s): 49884-589, 49884-590
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/10.2.2/0010